Prof. Noriyasu Fukushima
Department of Medical Science Technology
International University of Health and Welfare, Japan
Email: fukushin@iuhw.ac.jp
Qualifications
2013 Professor, International
University of Health and Welfare
2001 Doctor of Medical science, Saga Medical Graduate University
1994 Medical degree,
Saga Medical University
Publications
-
Ito Y, Kimura H, Maeda Y, Hashimoto C, Ishida F, Izutsu K,
Fukushima N, Isobe Y, Takizawa J, Hasegawa Y, Kobayashi H, Okamura S, Kobayashi
H, Yamaguchi M, Suzumiya J, Hyo R, Nakamura S, Kawa K, Oshimi K, Suzuki R.
Pretreatment EBV-DNA copy number is predictive of response and toxicities to
SMILE chemotherapy for extranodal NK/T-cell lymphoma, nasal type. Clin Cancer
Res 18;4183-4190, 2012
-
Kagami Y, Itoh K, Tobinai K, Fukuda H, Mukai K, Chou T, Mikuni C,
Kinoshita T, Fukushima N, Kiyama Y, Suzuki T, Sasaki T, Watanabe Y, Tsukasaki
K, Hotta T, Shimoyama M, Ogura M, The members of the Lymphoma Study Group of
the Japan Clinical Oncology Group. Phase II study of cyclophosphamide,
doxorubicin, vincristine, prednisolone (CHOP) therapy for newly diagnosed patients
with low- and low-intermediate risk, aggressive non-Hodgkin's lymphoma: final
results of the Japan Clinical Oncology Group Study, JCOG9508. Int J Hematol 96;
74-83, 2012
-
Itamura H, Fukushima N, Kondo S, Urata C, Tanaka-Yoshimura M,
Yokoo M, Ide M, Hisatomi T, Kubota Y, Sueoka E, Ichinohe T, Kimura S.
Successful reduced-intensity umbilical cord blood transplant for fulminant
hemophagocytic syndrome in an adult with pre-existing rheumatoid arthritis and
autoimmune hemolytic anemia. Leuk Lymphoma 53; 2307-2039, 2012
-
Azuma T, Tobinai K, Takeyama K, Shibata T, Hidaka M, Kurosawa M,
Kasai M, Chou T, Fukushima N, Mukai K, Tsukasaki K, Shimoyama M, Japan Clinical
Oncology Group-Lymphoma Study Group (JCOG-LSG) Phase II Study of Intensive
Post-remission Chemotherapy and Stem Cell Transplantation for Adult Acute
Lymphoblastic Leukemia and Lymphoblastic Lymphoma: Japan Clinical Oncology
Group Study, JCOG9402 Jpn J Clin Oncol 42; 394-404, 2012
-
Ureshino N, Aragane N, Nakamura T, Ide M, Mochinaga S, Fukushima
N, Hayashi S, Sueoka E, Kimura S A fully integrated and automated detection
system for single nucleotide polymorphisms of UGT1A1 and CYP2C19. Oncol Res 19;
111-4, 2011
-
Urata C, Yoshimura M, Itamura H, Hisatomi T, Kubota Y, Fukushima
N, Sueoka E, Kimura S Lenalidomide in combination with dexamethasone induced
rhabdomyolysis in a multiple myeloma patient treated with pravastatin. Int J
Hematol 94;216-7, 2011
-
Ide M, Fukushima N, Hisatomi T, Tsuneyoshi N, Tanaka M, Yokoo M,
Tomimasu R, Funai N, Sueoka E Non-germinal cell phenotype and bcl-2 expression
in primary adrenal diffuse large B-cell lymphoma. Leuk Lymphoma 48; 2244-6,
2007
-
Fukushima N, Mizuta T, Tanaka M, Yokoo M, Ide M, Hisatomi T,
Kuwahara N, Tomimasu R, Tsuneyoshi N, Funai N, Sueoka E Retrospective and
prospective studies of hepatitis B virus reactivation in malignant lymphoma
with occult HBV carrier. Ann Oncol 20; 2013-7, 2009
-
Fukushima N, Satoh T, Sueoka N, Sato A, Ide M, Hisatomi T,
Kuwahara N, Tomimasu R, Tsuneyoshi N, Funai N, Sano M, Tokunaga O, Sueoka E
Clinico- pathological characteristics of p63 expression in B-cell lymphoma.
Cancer Sci 97, 1050-5, 2006